Showing 19,501 - 19,520 results of 39,386 for search '(( significant ((level disease) OR (teer decrease)) ) OR ( significant decrease decrease ))', query time: 0.67s Refine Results
  1. 19501

    Supplementary file 1_Plasma FGF2 and YAP1 as novel biomarkers for MCI in the elderly: analysis via bioinformatics and clinical study.docx by Yejing Zhao (22123588)

    Published 2025
    “…The results showed that the expression levels of plasma FGF2 and YAP1 proteins in the MCI group were significantly higher compared to the control group. …”
  2. 19502
  3. 19503

    Table 1_Phospho-tau 181 is enhanced in saliva and plasma of edentulous patients: a first sign of dementia?.pdf by Christine Zürcher (21811382)

    Published 2025
    “…</p>Results<p>No changes were seen for salivary beta-amyloid and total tau; however, salivary pTau181 was significantly increased in edentulous patients. This was accompanied by enhanced plasma pTau181 levels.…”
  4. 19504
  5. 19505

    A) Expression of known ‘tendon’ transcription factors, B) TGFβ and C) ECM genes measured with RNA-seq. by Heather L. Dingwall (14573796)

    Published 2025
    “…Expression of ECM related genes are significantly differentially expressed in unique directions during postnatal stages with <i>Dcn</i> and <i>Fmod</i> increasing gradually over time, <i>Col2a1</i>, <i>Col14a1</i>, <i>Col3a1</i>, and <i>Tnmd</i> decreasing over time, <i>Col1a1</i> and <i>Col1a2</i> peak in expression at P14, and <i>Bgn</i> is expressed at higher levels from P0-P14 after which its levels decrease (C). …”
  6. 19506

    The effect of IFN-β and Vit D on the NF-κB and p-NF-κB protein. by Farzad Nasri (8941850)

    Published 2025
    “…NF-κB protein expression was reduced in all groups compared to the control, but not significantly <b>(A)</b>. IFN-β, Vit D, and the co-treatment all decrease p-NF-κB protein expression in comparison with the control, but it was only significant for the co-treatment group <b>(B)</b>. …”
  7. 19507

    Data Sheet 1_Major depressive disorders in children aged 5–14 years: a Global Burden of Disease analysis from the perspective of exercise psychology.xlsx by Wei Wei (21173)

    Published 2025
    “…While adolescent mental health has received growing attention, the burden and drivers of MDD in children aged 5–14 years remain inadequately characterized at the global level.</p>Methods<p>We conducted a comprehensive analysis using Global Burden of Disease (GBD) 2021 data to quantify trends in the prevalence, incidence, and disability-adjusted life years (DALYs) of MDD in children aged 5–14 years across 204 countries and territories from 1990 to 2021. …”
  8. 19508

    Image 2_Immune tolerance induction using the thyrotropin receptor epitope 78–94 (p37) prevents Graves’ disease in HLA-DR3 transgenic mice.jpeg by Hidefumi Inaba (5108207)

    Published 2025
    “…While the single-dose protocol failed to prevent disease, the step-up protocol, particularly when including the final 50 μg dose, significantly suppressed serum free thyroxine (FT4) and TRAb levels and prevented histopathological changes in the thyroid gland. …”
  9. 19509

    Image 4_Immune tolerance induction using the thyrotropin receptor epitope 78–94 (p37) prevents Graves’ disease in HLA-DR3 transgenic mice.jpeg by Hidefumi Inaba (5108207)

    Published 2025
    “…While the single-dose protocol failed to prevent disease, the step-up protocol, particularly when including the final 50 μg dose, significantly suppressed serum free thyroxine (FT4) and TRAb levels and prevented histopathological changes in the thyroid gland. …”
  10. 19510

    Image 1_Immune tolerance induction using the thyrotropin receptor epitope 78–94 (p37) prevents Graves’ disease in HLA-DR3 transgenic mice.jpeg by Hidefumi Inaba (5108207)

    Published 2025
    “…While the single-dose protocol failed to prevent disease, the step-up protocol, particularly when including the final 50 μg dose, significantly suppressed serum free thyroxine (FT4) and TRAb levels and prevented histopathological changes in the thyroid gland. …”
  11. 19511

    Image 3_Immune tolerance induction using the thyrotropin receptor epitope 78–94 (p37) prevents Graves’ disease in HLA-DR3 transgenic mice.jpeg by Hidefumi Inaba (5108207)

    Published 2025
    “…While the single-dose protocol failed to prevent disease, the step-up protocol, particularly when including the final 50 μg dose, significantly suppressed serum free thyroxine (FT4) and TRAb levels and prevented histopathological changes in the thyroid gland. …”
  12. 19512

    Image 5_Immune tolerance induction using the thyrotropin receptor epitope 78–94 (p37) prevents Graves’ disease in HLA-DR3 transgenic mice.jpeg by Hidefumi Inaba (5108207)

    Published 2025
    “…While the single-dose protocol failed to prevent disease, the step-up protocol, particularly when including the final 50 μg dose, significantly suppressed serum free thyroxine (FT4) and TRAb levels and prevented histopathological changes in the thyroid gland. …”
  13. 19513
  14. 19514
  15. 19515
  16. 19516
  17. 19517
  18. 19518
  19. 19519
  20. 19520